Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Dana Flanders is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/28/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/24/2025 | VALN | Buy Now | Valneva | $7.34 | 104.36% | Dana Flanders14% | $17 → $15 | Maintains | Buy | Get Alert |
| 05/18/2021 | IMPL | Buy Now | Impel Pharmaceuticals | — | — | Dana Flanders14% | → $32 | Initiates | → Buy | Get Alert |
| 01/22/2021 | SCYX | Buy Now | SCYNEXIS | $0.99 | 2420.16% | Dana Flanders14% | → $25 | Initiates | → Buy | Get Alert |
| 09/14/2020 | TRVN | Buy Now | Trevena | $1.25 | 300% | Dana Flanders14% | → $3125 | Initiates | → Buy | Get Alert |
| 09/08/2020 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | Dana Flanders14% | → $20 | Initiates | → Buy | Get Alert |
| 07/07/2020 | BLU | Buy Now | BELLUS Health | — | — | Dana Flanders14% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/27/2020 | PCRX | Buy Now | Pacira BioSciences | $24.79 | — | Dana Flanders14% | — | Initiates | → Neutral | Get Alert |
| 05/27/2020 | HRTX | Buy Now | Heron Therapeutics | $2.26 | 961.95% | Dana Flanders14% | → $24 | Initiates | → Buy | Get Alert |
| 05/27/2020 | FLXN | Buy Now | Flexion Therapeutics | — | — | Dana Flanders14% | → $20 | Initiates | → Buy | Get Alert |
| 05/27/2020 | COLL | Buy Now | Collegium Pharmaceutical | $29.58 | — | Dana Flanders14% | — | Initiates | → Neutral | Get Alert |
| 03/10/2020 | LGND | Buy Now | Ligand Pharmaceuticals | $108.40 | — | Dana Flanders14% | — | Initiates | → Neutral | Get Alert |
| 11/08/2019 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Dana Flanders14% | — | Initiates | → Neutral | Get Alert |
| 08/28/2019 | MYOV | Buy Now | Myovant Sciences | — | — | Dana Flanders14% | → $20 | Initiates | → Buy | Get Alert |
| 11/02/2018 | EBS | Buy Now | Emergent BioSolutions | $4.60 | 1530.43% | Dana Flanders14% | $60 → $75 | Upgrade | Neutral → Buy | Get Alert |
| 10/26/2018 | MYOV | Buy Now | Myovant Sciences | — | — | Dana Flanders14% | → $25 | Initiates | → Neutral | Get Alert |
| 09/11/2018 | ENDP | Buy Now | Endo International | — | — | Dana Flanders14% | $14 → $15 | Upgrade | Sell → Neutral | Get Alert |
| 08/17/2018 | LGND | Buy Now | Ligand Pharmaceuticals | $108.40 | 136.16% | Dana Flanders14% | → $256 | Initiates | → Neutral | Get Alert |
| 01/24/2018 | EBS | Buy Now | Emergent BioSolutions | $4.60 | 1095.65% | Dana Flanders14% | → $55 | Initiates | → Neutral | Get Alert |
| 12/01/2017 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Dana Flanders14% | → $75 | Initiates | → Buy | Get Alert |
| 09/28/2017 | ENDP | Buy Now | Endo International | — | — | Dana Flanders14% | → $7 | Initiates | → Sell | Get Alert |
| 09/28/2017 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Dana Flanders14% | → $18 | Initiates | → Neutral | Get Alert |
| 09/28/2017 | IPXL | Buy Now | Impax Laboratories | — | — | Dana Flanders14% | → $20 | Initiates | → Neutral | Get Alert |
| 09/27/2016 | IPXL | Buy Now | Impax Laboratories | — | — | Dana Flanders14% | $25 → $26 | Upgrade | Sell → Neutral | Get Alert |
| 06/06/2016 | ENDP | Buy Now | Endo International | — | — | Dana Flanders14% | → $20 | Initiates | → Neutral | Get Alert |
| 06/06/2016 | IPXL | Buy Now | Impax Laboratories | — | — | Dana Flanders14% | → $33 | Initiates | → Sell | Get Alert |
| 03/28/2016 | PTLA | Buy Now | Portola Pharmaceuticals | — | — | Dana Flanders14% | $65 → $30 | Downgrade | Buy → Neutral | Get Alert |
| 02/11/2015 | IPXL | Buy Now | Impax Laboratories | — | — | Dana Flanders14% | $33 → $41 | Downgrade | Buy → Neutral | Get Alert |
| 12/16/2013 | IPXL | Buy Now | Impax Laboratories, Inc. | — | — | Dana Flanders14% | → $29 | Initiates | → Buy | Get Alert |
| 09/17/2013 | ENDP | Buy Now | Endo International | — | — | Dana Flanders14% | → $52 | Assumes | → Buy | Get Alert |
| 10/31/2012 | IPXL | Buy Now | Impax Laboratories | — | — | Dana Flanders14% | $24 → $22 | Maintains | Sell | Get Alert |
| 10/03/2012 | IPXL | Buy Now | Impax Laboratories | — | — | Dana Flanders14% | $19 → $24 | Maintains | Sell | Get Alert |
| 08/06/2012 | ENDP | Buy Now | Endo International | — | — | Dana Flanders14% | $36 → $35 | Maintains | Neutral | Get Alert |
| 07/06/2012 | IPXL | Buy Now | Impax Laboratories | — | — | Dana Flanders14% | $20 → $19 | — | — | Get Alert |
